van Leeuwen, Flora H. P. http://orcid.org/0000-0002-8384-4385
Lena, Beatrice
Zwanenburg, Jaco J. M.
van Vulpen, Lize F. D.
Bartels, Lambertus W.
Fischer, Kathelijn
Nap, Frank J.
de Jong, Pim A.
Bos, Clemens
Foppen, Wouter
Funding for this research was provided by:
European Society of Musculoskeletal Radiology (Young Researcher Grant)
Article History
Received: 9 August 2021
Accepted: 18 October 2021
First Online: 2 December 2021
Declarations
:
: All patients or their legal guardians approved the use of their remnant samples for method development, validation, and research purposes, in agreement with Article 8. “Processing, storing, release and use of human biological material in accordance with ‘no objection’ procedure” of the University Medical Center Utrecht Biobank Regulations (version June 19, 2013).
: Not applicable
: The authors of this manuscript declare relationships with the following companies: WF has received research grants from NovoNordisk and Pfizer which were paid to the institution. LV received a research grant from CSL Behring which was paid to the institution and reports to be in the advisory boards of Swedish Orphan Biovitrum BV (sobi), Tremeau Pharmaceuticals and CSL Behring. KF has received speaker's fees from Bayer, Baxter/Shire, Biotest, CSL Behring, Octapharma, Pfizer, NovoNordisk; performed consultancy for Baxter/Shire, Biogen, CSL-Behring, Freeline, NovoNordisk, Pfizer, Roche and SOBI; and has received research support from Bayer, Pfizer, Baxter/Shire, and Novo Nordisk. PJ reported to perform consultancy for Sanifit and Inozyme. The Radiology department of the University Medical Center Utrecht received research support from Philips.